Literature DB >> 21803946

Acute and chronic angiotensin-(1-7) restores vasodilation and reduces oxidative stress in mesenteric arteries of salt-fed rats.

Gábor Raffai1, Matthew J Durand, Julian H Lombard.   

Abstract

This study determined the effect of ANG-(1-7) on salt-induced suppression of endothelium-dependent vasodilatation in the mesenteric arteries of male Sprague-Dawley rats. Chronic intravenous infusion of ANG-(1-7), oral administration of the nonpeptide mas receptor agonist AVE-0991, and acute preincubation of the arteries with ANG-(1-7) and AVE-0991 all restored vasodilator responses to both ACh and histamine that were absent in the arteries of rats fed a high-salt (4% NaCl) diet. The protective effects of ANG-(1-7) and AVE-0991 were inhibited by acute or chronic administration of the mas receptor antagonist A-779, the ANG II type 2 (AT(2)) receptor blocker PD-123319, or N-nitro-l-arginine methyl ester, but not the ANG II type 1 receptor antagonist losartan. Preincubation with the antioxidant tempol or the nitric oxide (NO) donor diethylenetriamine NONOate and acute and chronic administration of the AT(2) receptor agonist CGP-42112 mimicked the protective effect of ANG-(1-7) to restore vascular relaxation. Acute preincubation with ANG-(1-7) and chronic infusion of ANG-(1-7) ameliorated the elevated superoxide levels in rats fed a high-salt diet, but the expression of Cu/Zn SOD and Mn SOD enzyme proteins in the vessel wall was unaffected by ANG-(1-7) infusion. These results indicate that both acute and chronic systemic administration of ANG-(1-7) or AVE-0991 restore endothelium-dependent vascular relaxation in salt-fed Sprague-Dawley rats by reducing vascular oxidant stress and enhancing NO availability via mas and AT(2) receptors. These findings suggest a therapeutic potential for mas/AT(2) receptor activation in preventing the vascular oxidant stress and endothelial dysfunction associated with elevated dietary salt intake.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21803946      PMCID: PMC3197355          DOI: 10.1152/ajpheart.00202.2011

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  57 in total

Review 1.  The clinical implications of endothelial dysfunction.

Authors:  Michael E Widlansky; Noyan Gokce; John F Keaney; Joseph A Vita
Journal:  J Am Coll Cardiol       Date:  2003-10-01       Impact factor: 24.094

2.  Angiotensin-(1-7) prevents diabetes-induced attenuation in PPAR-gamma and catalase activities.

Authors:  Gursev S Dhaunsi; Mariam H M Yousif; Saghir Akhtar; Mark C Chappell; Debra I Diz; Ibrahim F Benter
Journal:  Eur J Pharmacol       Date:  2010-05-04       Impact factor: 4.432

Review 3.  Pharmacological effects of AVE 0991, a nonpeptide angiotensin-(1-7) receptor agonist.

Authors:  Robson A S Santos; Anderson J Ferreira
Journal:  Cardiovasc Drug Rev       Date:  2006 Fall-Winter

4.  Role of the angiotensin II AT2 receptor in inflammation and oxidative stress: opposing effects in lean and obese Zucker rats.

Authors:  Rifat Sabuhi; Quaisar Ali; Mohammad Asghar; Najah Riesh Hadi Al-Zamily; Tahir Hussain
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-05

5.  Angiotensin-(1-7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats.

Authors:  Pia E Walters; Tracey A Gaspari; Robert E Widdop
Journal:  Hypertension       Date:  2005-03-14       Impact factor: 10.190

6.  G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor.

Authors:  Evi Kostenis; Graeme Milligan; Arthur Christopoulos; Carlos F Sanchez-Ferrer; Silvia Heringer-Walther; Patrick M Sexton; Florian Gembardt; Elaine Kellett; Lene Martini; Patrick Vanderheyden; Heinz-Peter Schultheiss; Thomas Walther
Journal:  Circulation       Date:  2005-04-04       Impact factor: 29.690

7.  Angiotensin II AT2 receptors inhibit proximal tubular Na+-K+-ATPase activity via a NO/cGMP-dependent pathway.

Authors:  Amer C Hakam; Tahir Hussain
Journal:  Am J Physiol Renal Physiol       Date:  2005-12-27

8.  Characterization of a new angiotensin antagonist selective for angiotensin-(1-7): evidence that the actions of angiotensin-(1-7) are mediated by specific angiotensin receptors.

Authors:  R A Santos; M J Campagnole-Santos; N C Baracho; M A Fontes; L C Silva; L A Neves; D R Oliveira; S M Caligiorne; A R Rodrigues; C Gropen Júnior
Journal:  Brain Res Bull       Date:  1994       Impact factor: 4.077

9.  Effects of daily sodium intake and ANG II on cortical and medullary renal blood flow in conscious rats.

Authors:  V Gross; T M Kurth; M M Skelton; D L Mattson; A W Cowley
Journal:  Am J Physiol       Date:  1998-05

10.  The angiotensin receptor type 1-Gq protein-phosphatidyl inositol phospholipase Cbeta-protein kinase C pathway is involved in activation of proximal tubule Na+-ATPase activity by angiotensin(1-7) in pig kidneys.

Authors:  Lucienne S Lara; Juliana S Correa; Anouchka B Lavelle; Anibal G Lopes; Celso Caruso-Neves
Journal:  Exp Physiol       Date:  2008-02-01       Impact factor: 2.969

View more
  26 in total

1.  Suppressing inflammation by inhibiting the NF-κB pathway contributes to the neuroprotective effect of angiotensin-(1-7) in rats with permanent cerebral ischaemia.

Authors:  Teng Jiang; Li Gao; Jun Guo; Jie Lu; Yao Wang; Yingdong Zhang
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

Review 2.  New agents modulating the renin-angiotensin-aldosterone system-Will there be a new therapeutic option?

Authors:  Anna Gromotowicz-Poplawska; Piotr Szoka; Patrycjusz Kolodziejczyk; Karol Kramkowski; Marzena Wojewodzka-Zelezniakowicz; Ewa Chabielska
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-19

3.  Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: studies in vivo, ex vivo, and in vitro.

Authors:  Philipp K Haber; Minghao Ye; Jan Wysocki; Christoph Maier; Syed K Haque; Daniel Batlle
Journal:  Hypertension       Date:  2014-01-20       Impact factor: 10.190

Review 4.  Key developments in renin-angiotensin-aldosterone system inhibition.

Authors:  Bruno Sevá Pessôa; Nils van der Lubbe; Koen Verdonk; Anton J M Roks; Ewout J Hoorn; A H Jan Danser
Journal:  Nat Rev Nephrol       Date:  2012-11-20       Impact factor: 28.314

5.  Secreted Monocyte miR-27a, via Mesenteric Arterial Mas Receptor-eNOS Pathway, Causes Hypertension.

Authors:  Xue Zou; Jialiang Wang; Caiyu Chen; Xiaorong Tan; Yu Huang; Pedro A Jose; Jian Yang; Chunyu Zeng
Journal:  Am J Hypertens       Date:  2020-01-01       Impact factor: 2.689

6.  Amelioration of salt-induced vascular dysfunction in mesenteric arteries of Dahl salt-sensitive rats by missense mutation of extracellular superoxide dismutase.

Authors:  Andreas M Beyer; Gabor Raffai; Brian D Weinberg; Katherine Fredrich; Matthew S Rodgers; Aron M Geurts; Howard J Jacob; Melinda R Dwinell; Julian H Lombard
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-12-06       Impact factor: 4.733

Review 7.  Angiotensin-(1-7) and Alamandine on Experimental Models of Hypertension and Atherosclerosis.

Authors:  Fernando Pedro de Souza-Neto; Melissa Carvalho Santuchi; Mario de Morais E Silva; Maria José Campagnole-Santos; Rafaela Fernandes da Silva
Journal:  Curr Hypertens Rep       Date:  2018-03-14       Impact factor: 5.369

8.  Predominance of AT(1) blockade over mas-mediated angiotensin-(1-7) mechanisms in the regulation of blood pressure and renin-angiotensin system in mRen2.Lewis rats.

Authors:  Jasmina Varagic; Sarfaraz Ahmad; Jessica L VonCannon; Norihito Moniwa; K Bridget Brosnihan; Jan Wysocki; Daniel Batlle; Carlos M Ferrario
Journal:  Am J Hypertens       Date:  2013-03-04       Impact factor: 2.689

9.  Angiotensin-(1-7) Selectively Induces Relaxation and Modulates Endothelium-Dependent Dilation in Mesenteric Arteries of Salt-Fed Rats.

Authors:  Gábor Raffai; Julian H Lombard
Journal:  J Vasc Res       Date:  2016-09-28       Impact factor: 1.934

10.  Angiotensin-converting enzyme 2 activation improves endothelial function.

Authors:  Rodrigo A Fraga-Silva; Fabiana P Costa-Fraga; Tatiane M Murça; Patrícia L Moraes; Augusto Martins Lima; Roberto Q Lautner; Carlos H Castro; Célia Maria A Soares; Clayton L Borges; Ana Paula Nadu; Marilene L Oliveira; Vinayak Shenoy; Michael J Katovich; Robson A S Santos; Mohan K Raizada; Anderson J Ferreira
Journal:  Hypertension       Date:  2013-04-22       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.